Delirium, functional decline and quality of life after transcatheter aortic valve implantation: An explorative study
- PMID: 33098368
- PMCID: PMC7756254
- DOI: 10.1111/ggi.14064
Delirium, functional decline and quality of life after transcatheter aortic valve implantation: An explorative study
Abstract
Aim: Transcatheter aortic valve implantation (TAVI) has become an important treatment option for older patients with severe aortic stenosis. However, not all patients benefit from this procedure in terms of functional outcome and quality of life. This complicates patient selection and shared decision-making. Postoperative delirium might negatively affect patient outcomes after TAVI. We therefore studied the potential relationship between postoperative delirium and functional outcome, and how this impacts quality of life after TAVI.
Methods: This was a prospective cohort study of 91 consecutive patients undergoing TAVI between 2015 and 2017 at an academic medical center. All patients underwent a Comprehensive Geriatric Assessment before TAVI. Delirium symptoms were assessed daily during hospitalization. Follow up was carried out between 6 and 12 months postprocedure. The primary outcome was functional decline or death at follow up. Secondarily, we measured quality of life at follow up.
Results: The incidence of postoperative delirium was 15.4%. In total, 38.5% of patients experienced functional decline, and 11.0% died during a median follow-up period of 7 months. Delirium resulted in a fourfold increased odds of the combined outcome of functional decline or death. Quality of life was lower in patients that experienced this outcome.
Conclusion: In a cohort of TAVI patients, functional decline or death was a frequent outcome in the first year postprocedure. Postoperative delirium increased the odds for this outcome substantially. This suggests that delirium risk should be an important factor to consider in shared decision-making for TAVI patients. Geriatr Gerontol Int 2020; 20: 1202-1207.
Keywords: activities of daily living; cardiovascular surgery; delirium; quality of life; transcatheter aortic valve implantation.
© 2020 The Authors. Geriatrics & Gerontology International published by John Wiley & Sons Australia, Ltd on behalf of Japan Geriatrics Society.
Figures
References
-
- Leon MB, Smith CR, Mack M et al Transcatheter aortic‐valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597–1607. - PubMed
-
- Clark MA, Arnold SV, Duhay FG et al Five‐year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis. Circ Cardiovasc Qual Outcomes 2012; 5: 697–704. - PubMed
-
- Smith CR, Leon MB, Mack MJ et al Transcatheter versus surgical aortic‐valve replacement in high‐risk patients. N Engl J Med 2011; 364: 2187–2198. - PubMed
-
- Leon MB, Smith CR, Mack MJ et al Transcatheter or surgical aortic‐valve replacement in intermediate‐risk patients. N Engl J Med 2016; 374: 1609–1620. - PubMed
-
- Mack MJ, Leon MB, Thourani VH et al Transcatheter aortic‐valve replacement with a balloon‐expandable valve in low‐risk patients. N Engl J Med 2019; 380: 1695–1705. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
